Acclaimed oncologist receives $2.5 million endowed chair to fund precision cancer research efforts

Local family funds prestigious award to enable innovative studies, mentor the next generation of physician-scientists

By Amanda Gibbs April 13, 2018 Portland, Oregon

Downloads

Gordon Mills, M.D., Ph.D., director of precision oncology for the OHSU Knight Cancer Institute and a professor in the OHSU School of Medicine. (OHSU/Kristyna Wentz-Graff)

Gordon Mills, M.D., Ph.D.

Gordon Mills, M.D., Ph.D., director of precision oncology for the OHSU Knight Cancer Institute and a professor in the OHSU School of Medicine. (OHSU/Kristyna Wentz-Graff)

Drinkward endowment

Wayne and Julie Drinkward (left) have expanded their support of cancer research by establishing the Wayne and Julie Drinkward Endowed Chair in Precision Oncology at the OHSU Knight Cancer Institute. The recipient, Gordon Mills, M.D., Ph.D., is among the most highly cited medical scientists in the world. (OHSU/Kristyna Wentz-Graff)